EHMT1
Histone-lysine N-methyltransferase EHMT1
Also known as: bA188C12.1, EHMT1_HUMAN, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, GLP, KIAA1876, KMT1D
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H9B1
- Gene
- EHMT1
- Ensembl
- ENSG00000181090
- Chromosome
- 9
- Canonical length
- 1298 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
1298 residues, UniProt reviewed canonical sequence.
>Q9H9B1|EHMT1
1 MAAADAEAVP ARGEPQQDCC VKTELLGEET PMAADEGSAE KQAGEAHMAA DGETNGSCEN
61 SDASSHANAA KHTQDSARVN PQDGTNTLTR IAENGVSERD SEAAKQNHVT ADDFVQTSVI
121 GSNGYILNKP ALQAQPLRTT STLASSLPGH AAKTLPGGAG KGRTPSAFPQ TPAAPPATLG
181 EGSADTEDRK LPAPGADVKV HRARKTMPKS VVGLHAASKD PREVREARDH KEPKEEINKN
241 ISDFGRQQLL PPFPSLHQSL PQNQCYMATT KSQTACLPFV LAAAVSRKKK RRMGTYSLVP
301 KKKTKVLKQR TVIEMFKSIT HSTVGSKGEK DLGASSLHVN GESLEMDSDE DDSEELEEDD
361 GHGAEQAAAF PTEDSRTSKE SMSEADRAQK MDGESEEEQE SVDTGEEEEG GDESDLSSES
421 SIKKKFLKRK GKTDSPWIKP ARKRRRRSRK KPSGALGSES YKSSAGSAEQ TAPGDSTGYM
481 EVSLDSLDLR VKGILSSQAE GLANGPDVLE TDGLQEVPLC SCRMETPKSR EITTLANNQC
541 MATESVDHEL GRCTNSVVKY ELMRPSNKAP LLVLCEDHRG RMVKHQCCPG CGYFCTAGNF
601 MECQPESSIS HRFHKDCASR VNNASYCPHC GEESSKAKEV TIAKADTTST VTPVPGQEKG
661 SALEGRADTT TGSAAGPPLS EDDKLQGAAS HVPEGFDPTG PAGLGRPTPG LSQGPGKETL
721 ESALIALDSE KPKKLRFHPK QLYFSARQGE LQKVLLMLVD GIDPNFKMEH QNKRSPLHAA
781 AEAGHVDICH MLVQAGANID TCSEDQRTPL MEAAENNHLE AVKYLIKAGA LVDPKDAEGS
841 TCLHLAAKKG HYEVVQYLLS NGQMDVNCQD DGGWTPMIWA TEYKHVDLVK LLLSKGSDIN
901 IRDNEENICL HWAAFSGCVD IAEILLAAKC DLHAVNIHGD SPLHIAAREN RYDCVVLFLS
961 RDSDVTLKNK EGETPLQCAS LNSQVWSALQ MSKALQDSAP DRPSPVERIV SRDIARGYER
1021 IPIPCVNAVD SEPCPSNYKY VSQNCVTSPM NIDRNITHLQ YCVCIDDCSS SNCMCGQLSM
1081 RCWYDKDGRL LPEFNMAEPP LIFECNHACS CWRNCRNRVV QNGLRARLQL YRTRDMGWGV
1141 RSLQDIPPGT FVCEYVGELI SDSEADVREE DSYLFDLDNK DGEVYCIDAR FYGNVSRFIN
1201 HHCEPNLVPV RVFMAHQDLR FPRIAFFSTR LIEAGEQLGF DYGERFWDIK GKLFSCRCGS
1261 PKCRHSSAAL AQRQASAAQE AQEDGLPDTS SAAAADPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EHMT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- testis: 39 nTPM
- skeletal muscle: 29 nTPM
- bone marrow: 29 nTPM
- lymph node: 28 nTPM
- spleen: 24 nTPM
- thymus: 21 nTPM
Single-cell type
- plasma cells: 517 nCPM
- renal collecting duct principal cells: 309 nCPM
- late spermatids: 289 nCPM
- papillary tip epithelial cells: 252 nCPM
- b-cells: 230 nCPM
- podocytes: 228 nCPM
Immune cell
- neutrophil: 29 nTPM
- plasmacytoid DC: 23 nTPM
- naive B-cell: 23 nTPM
- eosinophil: 21 nTPM
- basophil: 20 nTPM
- gdT-cell: 18 nTPM
Brain region
- white matter: 80 nTPM
- cerebellum: 74 nTPM
- choroid plexus: 71 nTPM
- thalamus: 68 nTPM
- cerebral cortex: 67 nTPM
- basal ganglia: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EHMT1.
Disease | AllUniProt
Conditions EHMT1 is implicated in, by any mechanism.
- Kleefstra syndrome 1 (KLEFS1) MIM:610253
Disease | GeneticClinVar
269 pathogenic / likely-pathogenic of 2,520 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.07
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- beige fat cell differentiation
- brown fat cell differentiation
- chromatin organization
- DNA methylation-dependent constitutive heterochromatin formation
- epigenetic regulation of gene expression
- facultative heterochromatin formation
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- negative regulation of white fat cell differentiation
- peptidyl-lysine dimethylation
- peptidyl-lysine monomethylation
- positive regulation of cold-induced thermogenesis
- regulation of embryonic development
- response to fungicide
Molecular functions
- C2H2 zinc finger domain binding
- histone H3K27 methyltransferase activity
- histone H3K9 methyltransferase activity
- histone H3K9 monomethyltransferase activity
- histone H3K9 trimethyltransferase activity
- histone H3K9me2 methyltransferase activity
- methyltransferase activity
- p53 binding
- protein-lysine N-methyltransferase activity
- transcription corepressor binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Ankyrin repeat
- Pre-SET domain
- Ankyrin repeat-containing domain superfamily
- Histone-lysine N-methyltransferase EHMT1/EHMT2
- SET domain superfamily
- EHMT1/2, cysteine-rich region
- SET domain
- Pre-SET motif
- Ankyrin repeats (3 copies)
- Ankyrin repeats (many copies)
- Histone-lysine N-methyltransferase EHMT1/EHMT2, Cys-rich region
- Histone-lysine N-methyltransferase EHMT1, SET domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EHMT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EHMT1 as an antibody target. Whether an autoantibody or antibody against EHMT1 could matter depends on whether native EHMT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EHMT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EHMT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...